Rat & Mouse Model Market by Model Type (Conditioned or Surgically Modified Rats, Genetically Modified Rats, Hybrid or Congenic Rats), Technology (CRISPR, Embryonic Stem Cell Injection, Microinjection), Care Product, Service, Therapeutic Area, End-User - G

Rat & Mouse Model Market by Model Type (Conditioned or Surgically Modified Rats, Genetically Modified Rats, Hybrid or Congenic Rats), Technology (CRISPR, Embryonic Stem Cell Injection, Microinjection), Care Product, Service, Therapeutic Area, End-User - Global Forecast 2024-2030


The Rat & Mouse Model Market size was estimated at USD 2.26 billion in 2023 and expected to reach USD 2.37 billion in 2024, at a CAGR 5.41% to reach USD 3.27 billion by 2030.

Global Rat & Mouse Model Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Rat & Mouse Model Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Rat & Mouse Model Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Rat & Mouse Model Market, highlighting leading vendors and their innovative profiles. These include Biomere Biomedical Research Models, Inc., Charles River Laboratories International, Inc., Envigo by Inotiv, Inc., GenOway S.A., Harbour Biomed, Ingenious Targeting Laboratory, Janvier Labs, Ozgene Pty Ltd., PerkinElmer, Inc., PolyGene AG, Taconic Biosciences, Inc., and TransViragen, Inc..

Market Segmentation & Coverage



This research report categorizes the Rat & Mouse Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

Model Type
Conditioned or Surgically Modified Rats
Genetically Modified Rats
Hybrid or Congenic Rats
Immunodeficient Rats
Inbred Rats
Outbred Rats
Technology
CRISPR
Embryonic Stem Cell Injection
Microinjection
Nuclear Transfer
Care Product
Bedding
Cages
Feed
Service
Breeding
Cryopreservation
Genetic Testing
Model-in-Licensing
Quarantine
Rederivation
Therapeutic Area
Diabetes
Immunology & Inflammation
Neurology
Oncology
Toxicology
End-User
Academic & Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Rat & Mouse Model Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Rat & Mouse Model Market?
3. What are the technology trends and regulatory frameworks in the Rat & Mouse Model Market?
4. What is the market share of the leading vendors in the Rat & Mouse Model Market?
5. Which modes and strategic moves are suitable for entering the Rat & Mouse Model Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Rat & Mouse Model Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant demand for genetically modified models to validate therapeutic targets
5.1.1.2. Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
5.1.1.3. Surge in demand for personalized medicine
5.1.2. Restraints
5.1.2.1. Ethical concerns and limitation of rat & mouse model
5.1.3. Opportunities
5.1.3.1. Inclination towards humanized rat & mouse model
5.1.3.2. Growing therapeutic research areas
5.1.4. Challenges
5.1.4.1. Presence of alternative testing methods
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Rat & Mouse Model Market, by Model Type
6.1. Introduction
6.2. Conditioned or Surgically Modified Rats
6.3. Genetically Modified Rats
6.4. Hybrid or Congenic Rats
6.5. Immunodeficient Rats
6.6. Inbred Rats
6.7. Outbred Rats
7. Rat & Mouse Model Market, by Technology
7.1. Introduction
7.2. CRISPR
7.3. Embryonic Stem Cell Injection
7.4. Microinjection
7.5. Nuclear Transfer
8. Rat & Mouse Model Market, by Care Product
8.1. Introduction
8.2. Bedding
8.3. Cages
8.4. Feed
9. Rat & Mouse Model Market, by Service
9.1. Introduction
9.2. Breeding
9.3. Cryopreservation
9.4. Genetic Testing
9.5. Model-in-Licensing
9.6. Quarantine
9.7. Rederivation
10. Rat & Mouse Model Market, by Therapeutic Area
10.1. Introduction
10.2. Diabetes
10.3. Immunology & Inflammation
10.4. Neurology
10.5. Oncology
10.6. Toxicology
11. Rat & Mouse Model Market, by End-User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations
11.4. Pharmaceutical & Biotechnology Companies
12. Americas Rat & Mouse Model Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Rat & Mouse Model Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Rat & Mouse Model Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. Biomere Biomedical Research Models, Inc.
16.1.2. Charles River Laboratories International, Inc.
16.1.3. Envigo by Inotiv, Inc.
16.1.4. GenOway S.A.
16.1.5. Harbour Biomed
16.1.6. Ingenious Targeting Laboratory
16.1.7. Janvier Labs
16.1.8. Ozgene Pty Ltd.
16.1.9. PerkinElmer, Inc.
16.1.10. PolyGene AG
16.1.11. Taconic Biosciences, Inc.
16.1.12. TransViragen, Inc.
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
FIGURE 1. RAT & MOUSE MODEL MARKET RESEARCH PROCESS
FIGURE 2. RAT & MOUSE MODEL MARKET SIZE, 2023 VS 2030
FIGURE 3. RAT & MOUSE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RAT & MOUSE MODEL MARKET DYNAMICS
FIGURE 7. RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2030 (%)
FIGURE 8. RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RAT & MOUSE MODEL MARKET SIZE, BY CARE PRODUCT, 2023 VS 2030 (%)
FIGURE 12. RAT & MOUSE MODEL MARKET SIZE, BY CARE PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 14. RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 16. RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 18. RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 28. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings